Scancell Holdings (SCLP)

 

Latest News

Notice of AGM

RNS Number: 6869Q Scancell Holdings Plc 14 September 2017 14 September 2017 Scancell Holdings Plc ("Scancell" or the "Company") Notice of AGM Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment of cancer, will host its Annual General Meeting on Tuesday 10 October 2017. The AGM details are as follows: ...

Weak mining and consumer stocks hit FTSE

Mining stocks were the main casualties this morning as BHP Billiton (BLT), Fresnillo (FRES) and Anglo American (AAL) ...

Scancell reports good progress in development of Modi-1

Scancell reported continued good progress in development of Modi-1, the lead product from the Moditope platform in the y...

Final Results

RNS Number: 5643Q Scancell Holdings Plc 13 September 2017 13 September 2017 Scancell Holdings Plc ("Scancell" or the "Company") Final Results for the year ended 30 April 2017 Landmark five year survival achieved in resected SCIB1 patients Emerging pipeline of three products across five cancer indications Scancell Holdings plc, ('Group' or the 'Company') the dev...

All News

DateHeadlineSource
14-09-17Notice of AGMRNS
13-09-17Weak mining and consumer stocks hit FTSEStockMarketWire
13-09-17Scancell reports good progress in development of Modi-1StockMarketWire
13-09-17Final ResultsRNS
11-09-17Presents Moditope Data at Immunotherapy ConferenceRNS
29-08-17Oncimmune and Scancell Present Autoantibodies DataRNS
11-07-17Scancell notes continued progress on SCIB1StockMarketWire
11-07-17Continued Progress on SCIB1RNS
26-06-17Scancell notes ImmunoBody patent granted in EuropeStockMarketWire
26-06-17DNA ImmunoBody Patent Granted in EuropeRNS
22-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
19-05-17Holding(s) in CompanyRNS
11-05-17Results of PlacingRNS
11-05-17Scancell proposes raising up to £5.0mStockMarketWire
11-05-17Proposed Placing to Raise up to ?5.0 millionRNS
13-04-17Scancell changes registered officeStockMarketWire
13-04-17Change of Registered OfficeRNS
20-03-17Immuno-Oncology Summit Europe 2017RNS
13-03-17Scancell eyes fundraising for Phase II SCIB1 trialStockMarketWire
13-03-17Hardman Research: SCIB development updateRNS
01-03-17Holding(s) in CompanyRNS
31-01-17Scancell widens H1 pretax lossStockMarketWire
31-01-17Interim ResultsRNS
30-01-17Scancell in partnership to advance lung cancer clinical trialsStockMarketWire
30-01-17Partnership to Advance Lung Cancer Clinical TrialsRNS
03-01-17Research Update - AmendmentRNS
03-01-17Scancell Holdings issues research updateStockMarketWire
03-01-17Research UpdateRNS
14-11-16World Immunotherapy Congress and Biotech and MoneyRNS
18-10-16Results of AGMRNS
10-10-16Preparing SCIB2 for clinical study in lung cancerRNS
26-09-16Hardman Report: New frontiers in T-cell activationRNS
23-09-16Notice of AGM - AmendmentRNS
23-09-16Scancell Holdings schedules AGMStockMarketWire
23-09-16Notice of AGMRNS
16-09-16Scancell widens H1 pretax loss StockMarketWire
16-09-16Final ResultsRNS
07-09-16NewsMakers in the Biotech Industry ConferenceRNS
22-08-16Appointment of Non-Executive DirectorRNS

RSS feeds

  • Editorial news feed for LSE:SCLP Editorial
  • Regulatory news feed for LSE:SCLP Regulatory